Cognition Therapeutics, Inc., today announced the appointment of John Doyle to the role of Chief Financial Officer. Mr. Doyle has substantial experience leading and managing financial operations at development- and commercial-stage public life sciences companies through financings, mergers, acquisitions and licensing agreements.
CFO at Cognition Therapeutics
May 1, 2023